Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
CG Oncology Inc. is a late-stage clinical biopharmaceutical company focused on developing therapeutics to treat bladder cancer. Their lead asset,...
— TimesSquare Capital Management LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on CG Oncology, Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from TimesSquare Capital Management U.S. Mid Cap Growth Strategy